Contact us

Sending Email...

Valid input required
Valid input required
Valid input required
Valid input required
Valid input required
Valid input required

STORY

Acoustic camera finds air leaks

By visually pinpointing leaks, we can address them more effectively, saving energy and aligning with our commitment to sustainability. 



When it comes to protecting the environment, every effort counts. Several Nolato companies have therefore joined forces and invested in an acoustic camera that detects air leaks.

Compressed air and vacuum systems are energy intensive, and leaks make them even more so. Besides costing money, this doesn’t really sit well with Nolato’s goal of cutting energy usage. 

Compressed air and vacuum piping often spans large areas of the business, with numerous connectors, pipes and hoses. Filming with the acoustic camera along the tubing and piping using the handheld device provides a visual image of the leaks, and gives an idea of the annual cost in terms of energy. 

“Otherwise we would have had to largely rely on listening for the leaks, which is tricky in the production environment of our plants,” notes Mats Carlsson, Facility Manager at Nolato MediTech in Hörby, Sweden. 
 

 

  • Nolato MediTech
  • Nolato
  • Sustainability
  • Nolato Magasin

You might also be interested in

STORIES

Nolato is one of the leading global players in silicone injection molding

With four development and production units in Europe and North America in its Medical Solutions business area, Nolato has significant capabilities to meet customer needs within both liquid and hard silicone. Read more here.

STORIES

Design for disassembly

The most effective way of making a plastic product environmentally friendly is to make sure that the products is recycled. When it is not possible to design the entire product in the same material it needs to be easy to take apart.

STORIES

New long-term cooperation agreement

Nolato has signed a long-term cooperation agreement with a major customer to supply medical devices for drug administration. This partnership will support treatment for obesity and diabetes, with full-scale production expected to generate SEK 700 million annually. Learn more about this significant collaboration and the journey to securing the contract here: